Solid Biosciences (SLDB) News Today $4.37 +0.11 (+2.58%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$4.36 -0.01 (-0.34%) As of 03/27/2025 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Truist Financial Keeps Their Buy Rating on Solid Biosciences (SLDB)March 21, 2025 | markets.businessinsider.comSolid Biosciences Inc. (SLDB): Among Top Insider Purchases Last MonthMarch 14, 2025 | insidermonkey.comJPMorgan Chase & Co. Issues Pessimistic Forecast for Solid Biosciences (NASDAQ:SLDB) Stock PriceJPMorgan Chase & Co. lowered their price objective on Solid Biosciences from $12.00 to $11.00 and set an "overweight" rating for the company in a research report on Thursday.March 14, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Stock Price Up 0.5% - Still a Buy?Solid Biosciences (NASDAQ:SLDB) Trading Up 0.5% - What's Next?March 13, 2025 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of "Buy" from BrokeragesShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have been given an average rating of "Buy" by the thirteen analysts that are covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation and four have issued a strong buy recommenMarch 13, 2025 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Short Interest UpdateSolid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 7,320,000 shares, an increase of 148.1% from the February 13th total of 2,950,000 shares. Based on an average trading volume of 2,130,000 shares, the days-to-cover ratio is presently 3.4 days. Currently, 12.3% of the company's shares are sold short.March 13, 2025 | marketbeat.comSolid Biosciences (SLDB) Receives a Buy from J.P. MorganMarch 12, 2025 | markets.businessinsider.comSolid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific ConferenceMarch 12, 2025 | globenewswire.comEquities Analysts Offer Predictions for SLDB Q1 EarningsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Research analysts at HC Wainwright lifted their Q1 2025 EPS estimates for shares of Solid Biosciences in a report released on Monday, March 10th. HC Wainwright analyst A. He now expects that the company will post earnings of ($0.43) per share fMarch 12, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Trading Down 4.9% - What's Next?Solid Biosciences (NASDAQ:SLDB) Shares Down 4.9% - Here's WhyMarch 11, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Shares Down 3.1% - Here's What HappenedSolid Biosciences (NASDAQ:SLDB) Trading Down 3.1% - Here's What HappenedMarch 11, 2025 | marketbeat.comSolid Biosciences price target raised to $20 from $16 at H.C. WainwrightMarch 10, 2025 | markets.businessinsider.comSolid Biosciences (SLDB) Gets a Buy from Truist FinancialMarch 10, 2025 | markets.businessinsider.comHC Wainwright Increases Solid Biosciences (NASDAQ:SLDB) Price Target to $20.00HC Wainwright raised their target price on Solid Biosciences from $16.00 to $20.00 and gave the company a "buy" rating in a research note on Monday.March 10, 2025 | marketbeat.comFY2026 Earnings Forecast for SLDB Issued By William BlairSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Investment analysts at William Blair issued their FY2026 earnings estimates for shares of Solid Biosciences in a note issued to investors on Friday, March 7th. William Blair analyst S. Corwin forecasts that the company will earn ($2.76) per shaMarch 10, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Receives "Buy" Rating from Chardan CapitalChardan Capital reiterated a "buy" rating and issued a $16.00 target price on shares of Solid Biosciences in a research note on Friday.March 8, 2025 | marketbeat.comSolid Biosciences Reports Positive Data from Duchenne Gene Therapy Trial and Provides Business UpdateMarch 8, 2025 | nasdaq.comSolid Biosciences (SLDB) Gets a Buy from Chardan CapitalMarch 7, 2025 | markets.businessinsider.comSolid Biosciences (NASDAQ:SLDB) Posts Earnings Results, Misses Expectations By $0.12 EPSSolid Biosciences (NASDAQ:SLDB - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.89) earnings per share for the quarter, missing analysts' consensus estimates of ($0.77) by ($0.12).March 7, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Releases Earnings Results, Misses Expectations By $0.12 EPSSolid Biosciences (NASDAQ:SLDB - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.89) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.77) by ($0.12).March 7, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Stock Price Down 1.1% - What's Next?Solid Biosciences (NASDAQ:SLDB) Stock Price Down 1.1% - What's Next?March 7, 2025 | marketbeat.comPiper Sandler Remains a Buy on Solid Biosciences (SLDB)March 7, 2025 | markets.businessinsider.comSolid Biosciences Inc.: Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdatesMarch 7, 2025 | finanznachrichten.deSolid Biosciences files to sell 364,990 shares of common stock for holdersMarch 7, 2025 | markets.businessinsider.comBarclays Remains a Buy on Solid Biosciences (SLDB)March 7, 2025 | markets.businessinsider.comSolid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdatesMarch 6, 2025 | globenewswire.comSolid Biosciences to Participate at Upcoming Investor ConferencesMarch 5, 2025 | globenewswire.comSolid Biosciences (SLDB) Expected to Announce Quarterly Earnings on WednesdaySolid Biosciences (NASDAQ:SLDB) will be releasing earnings before the market opens on Wednesday, March 12, Financial Modeling Prep reports.March 5, 2025 | marketbeat.comIs Solid Biosciences Inc. (SLDB) Among Stocks With At Least $20 Million In Insider Spending Recently?March 4, 2025 | insidermonkey.comSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 4, 2025 | globenewswire.comSolid Biosciences' SWOT analysis: gene therapy stock poised for pivotal dataFebruary 28, 2025 | uk.investing.comSolid Biosciences Inc.'s (NASDAQ:SLDB) stock price dropped 11% last week; individual investors would not be happyFebruary 28, 2025 | finance.yahoo.comLeerink Partnrs Analysts Boost Earnings Estimates for SLDBSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Stock analysts at Leerink Partnrs raised their Q1 2025 EPS estimates for shares of Solid Biosciences in a report released on Sunday, February 23rd. Leerink Partnrs analyst J. Schwartz now anticipates that the company will earn ($0.36) per shareFebruary 26, 2025 | marketbeat.comEquities Analysts Set Expectations for SLDB FY2025 EarningsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Chardan Capital increased their FY2025 earnings estimates for shares of Solid Biosciences in a note issued to investors on Wednesday, February 19th. Chardan Capital analyst Y. Livshits now anticipates that the company will post earnings per shaFebruary 24, 2025 | marketbeat.comCantor Fitzgerald Brokers Boost Earnings Estimates for SLDBSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Equities research analysts at Cantor Fitzgerald boosted their FY2025 earnings estimates for Solid Biosciences in a research report issued on Wednesday, February 19th. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will posFebruary 22, 2025 | marketbeat.comResearch Analysts Issue Forecasts for SLDB FY2025 EarningsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Research analysts at Cantor Fitzgerald lifted their FY2025 earnings per share (EPS) estimates for Solid Biosciences in a research report issued on Wednesday, February 19th. Cantor Fitzgerald analyst C. Duncan now forecasts that the company willFebruary 21, 2025 | marketbeat.comWedbush Increases Earnings Estimates for Solid BiosciencesSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Wedbush lifted their Q1 2025 earnings per share estimates for Solid Biosciences in a note issued to investors on Wednesday, February 19th. Wedbush analyst L. Chico now anticipates that the company will post earnings per share of ($0.60) for theFebruary 21, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Given New $16.00 Price Target at Chardan CapitalChardan Capital increased their target price on shares of Solid Biosciences from $15.00 to $16.00 and gave the stock a "buy" rating in a report on Wednesday.February 20, 2025 | marketbeat.comTruist Financial Sticks to Its Buy Rating for Solid Biosciences (SLDB)February 19, 2025 | markets.businessinsider.comSolid Biosciences Soars 32% on Trial Data: 189% Upside from Here?Solid Biosciences just saw a 32% move to the upside after its trial results impressed. What's next for this firm that analysts still see massive potential in?February 19, 2025 | marketbeat.comJMP Securities Keeps Their Buy Rating on Solid Biosciences (SLDB)February 19, 2025 | markets.businessinsider.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives $15.30 Average PT from AnalystsShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have earned an average rating of "Buy" from the thirteen research firms that are covering the stock, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy rating and four have issued a strong buyFebruary 19, 2025 | marketbeat.comSolid Biosciences stock soars on promising Duchenne therapy dataFebruary 19, 2025 | uk.investing.comSolid Biosciences Stock Surges On Upbeat Duchenne Muscular Dystrophy Gene Therapy DataFebruary 19, 2025 | benzinga.comSolid Biosciences reports initial clinical data from INSPIRE DUCHENNE trialFebruary 19, 2025 | markets.businessinsider.comSolid Bio surges after trial data for lead asset in DuchenneFebruary 19, 2025 | msn.comSolid Biosciences price target raised to $16 from $15 at ChardanFebruary 19, 2025 | markets.businessinsider.comSolid Biosciences' Retail Following Swells Amid Stock's Best Run In A Year — What's Behind The Move?February 19, 2025 | msn.comSolid Biosciences Announces Pricing of Underwritten OfferingFebruary 18, 2025 | globenewswire.comSolid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003February 18, 2025 | globenewswire.com Remove Ads Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address SLDB Media Mentions By Week SLDB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLDB News Sentiment▼1.100.78▲Average Medical News Sentiment SLDB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLDB Articles This Week▼23▲SLDB Articles Average Week Remove Ads Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ANI Pharmaceuticals News Today Dyne Therapeutics News Today Indivior News Today Amphastar Pharmaceuticals News Today 89bio News Today Adaptive Biotechnologies News Today Evotec News Today ARS Pharmaceuticals News Today Ardelyx News Today Ocular Therapeutix News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLDB) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
